SCOTUS, New Mexico and the abortion pill

Your definitive guide to women, politics and power.
Feb 02, 2024 View in browser
 
Women Rule logo

By Sophie Gardner

New Mexico Gov. Michelle Lujan Grisham is pictured.

POLITICO illustration/Photos by AP, iStock

Hi Rulers! Happy February! Send me your thoughts and ideas for this newsletter (and wildest NFL/Taylor Swift conspiracy theories): sgardner@politico.com. I've got a Q&A for you today:

In just two months, the Supreme Court is slated to hear oral arguments in its first significant case on abortion since it overturned Roe v. Wade.

The two consolidated cases — F.D.A. v. Alliance for Hippocratic Medicine and Danco Laboratories v. Alliance for Hippocratic Medicine, could change how patients can access a popular abortion drug, Mifepristone, which is used in over half of abortions nationwide.

The case challenges policies, made in recent years by the FDA, which allow the drug to be used until 10 weeks of pregnancy (the SCOTUS decision could roll that back to seven), and allow the drug to be prescribed online and mailed to patients.

The case has broad implications in states that already have strict abortion bans, where some women rely on telehealth and mail to receive their medication.

But it also has broad implications for states where abortion is legal, which could see an influx of patients from conservative states who are no longer able to access abortion medication through the mail.

One of those states is New Mexico, which has already seen an exponential increase in abortions post-Dobbs, largely due to its sprawling border with Texas.

By some estimates, it is the state where abortion has spiked the most.

This week, I talked to New Mexico Gov. Michelle Lujan Grisham, a Democrat, about that challenge and her decision to sign onto an amicus brief, urging the Supreme Court to side with the FDA, with 21 other pro-abortion rights governors — a group known as the Reproductive Freedom Alliance.

Here's our conversation, which has been edited for length and clarity.

Gardner: New Mexico is a rural state. This decision might change residents' abilities to receive abortion medication through the mail. Are you concerned about having enough clinics in rural areas to meet demand?

Lujan Grisham: This case has dire consequences for women's health, infections, having sufficient providers and getting them into rural New Mexico and into rural America.

The goal is always to do the least intrusive work. Medicated abortions are the least intrusive.

One thing that's getting lost here is that women — through no fault of their own — will continue to suffer miscarriages. Mifepristone is an effective medication to treat miscarriage management, without which there are other dire consequences, including the kind of issues and infections where women have ended up with full or partial hysterectomies.

It's outrageous. This medication has to be available.

Gardner: If the Supreme Court rules against the FDA, as governor, how will you handle that?

Lujan Grisham: We’re all going to have to figure that out. The first line of offense here is to make sure that we show the legal issues.

The FDA is responsible for aiding states with its decision making and its role in any number of public health efforts. The HPV vaccine is another critical example. Make no mistake, I think that could be at risk. I think birth control pills and condoms could be at risk.

I will do, legally and ethically, whatever it takes to protect women and their families in New Mexico, but it's uncharted territory, for sure. So the objective here is to make sure that our legal arguments win the day.

Gardner: New Mexico has had an experience that somewhat reflects what’s going on nationally. I know you had several towns create anti-abortion ordinances. Specifically, I’m thinking of Edgewood, which created an ordinance that was intended to bar the reception of abortion drugs or other abortion-related items by mail. Can you speak a bit about how you handled that?

Lujan Grisham: The Dobbs decision itself opened the door to finding any mechanism to prevent reproductive health care access. And anti-abortion advocates certainly exist in my state, but I'm going to talk about the legal aspect.

Now, we're interfering with the mail. By that logic, you could, say, not be allowed to get Viagra by mail potentially somewhere. Or adult information. You could ban certain books people get by mail. It would have far reaching consequences.

You cannot do that, legally. They've been told they can't do it, but they're gonna keep doing it because it's really a political stunt.

We make sure that everyone in the community knows that there's no enforcement.

But it’s the consequence, again, of Dobbs.

Gardner: If SCOTUS restricts the ability to mail Mifepristone, are you worried about a possible influx of patients from other states? Would that strain New Mexico's resources?

Lujan Grisham: We will work to be prepared. It's one of the reasons I invested in building a clinic. We're gonna have to expand access and care and all of these clinical services that do the full range of reproductive health services, including abortion.

This will no doubt have a huge impact. Already, 72 percent of the abortions in New Mexico are for Texas residents.

Gardner: We saw that Dobbs had a major impact on the 2022 midterms. Whichever way this case goes, do you think it will impact the 2024 election?

Lujan Grisham: I do. And we'll have to see if our speculations are right, but based on the current polling for women, in a Biden-Trump match-up, you can see the shift.

They’re not talking about women's health care access in the Republican primary, because it's not a good issue for them. Because in my eyes, they're wrong on this issue. And they're wrong about the American sentiment on this issue.

I think it'll play a primary role in the outcomes of the election and in voter participation. This is an issue that bridges all socio-economic status when a lot of issues don't.

POLITICO Special Report

President Joe Biden, left, greets patrons at They Say restaurant during a campaign stop Feb. 1, 2024, in Harper Woods, Mich.

AP Photo/Evan Vucci

Gender gap expands between Biden and Trump, new poll shows,” by Christine Zhu for POLITICO: “More women said they would support Biden over Trump in this latest survey, with 58 percent backing Biden and 36 percent backing Trump. Last month, the Quinnipiac poll found 53 percent of women supported the incumbent Democrat, compared to 41 percent for the Republican challenger.”

Florida Democrat launches bid to become first Gen Z woman member of Congress,” by Kimberly Leonard for POLITICO: “Sabrina Bousbar, senior adviser on emergency preparedness in the Biden administration, is running to challenge U.S. Rep. Anna Paulina Luna (R-Fla.) in Florida’s 13th Congressional district.

“The seat was previously held by Democratic Rep. Charlie Crist. She’d be the first woman Generation Z member of Congress if elected.”

When QAnon fundraises for Kari Lake ... she shows up,” by Daniel Lippman for POLITICO: “Caryn and Michael Borland, who have shared numerous QAnon posts on their social media platforms, are holding the fundraiser for the likely GOP nominee at their mansion in Prescott, Arizona.

Number of the Week

Text reads: Biden gained 5 percentage points with women since December in a match-up with Trump, according to a Quinnipiac University National Poll.

Read more here.

MUST READS

Then-President Donald Trump stands in the colonnade as he is introduced to speak to March for Life participants and pro-life leaders in the Rose Garden at the White House on Jan. 19, 2018 in Washington, D.C.

Mark Wilson/Getty Images

The tools Trump could use to curb abortion access if he’s elected,” by Shefali Luthra and Mel Leonor Barclay for The 19th News: “Without the aid of Congress, the former president would have tools to quickly curtail access to the procedure — and the pressure on him to wield them has already started. ”

These women support abortion rights. They’re still voting Trump,” by Ben Kamisar and Mark Murray for NBC News.

Israeli Women Fight on Front Line in Gaza, a First,” by Isabel Kershner for The New York Times: “The integration of women into the military’s combat units has been the subject of a lengthy debate in Israel, home to one of the world’s few armies that conscript women at 18 for mandatory service. For years the question of women serving at the front pitted ultraconservative rabbis and religiously observant soldiers against feminists, secularists and critics of the country’s traditionally macho culture.

“Now, that debate is effectively over.”

Trump’s attacks on Haley pose risks with female voters,” by Julia Manchester for The Hill.

Quote of the Week

Text reads: “It’s striking that the only leaders that were condemned to this degree were women.” — Daphna Shohamy, a neuroscientist and director of the Zuckerman Mind Brain Behavior Institute at Columbia, on the recent controversy over Ivy League presidents’ responses to the Israel-Hamas war

Read more here.

on the move

The Science Coalition has elected Jill Pentimonti as its new president. She currently serves as the University of Notre Dame’s Director of Research Advancement.

Sarah Christopherson will be senior legislative adviser at Patriotic Millionaires. She previously was legislative and policy director at Americans for Tax Fairness.

Vernessa Pollard is now a partner and co-chair of DLA Piper’s FDA Practice. She previously has been a partner and FDA practice leader at McDermott Will & Emery. (h/t Playbook)

 

Follow us on Twitter

Sophie Gardner @sophie_gardnerj

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to salenamartine360.news1@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

Post a Comment

Previous Post Next Post